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Abstract
Background: The variations within an individual's HLA (Human Leukocyte Antigen) genes have
been linked to many immunological events, e.g. susceptibility to disease, response to vaccines, and
the success of blood, tissue, and organ transplants. Although the microarray format has the
potential to achieve high-resolution typing, this has yet to be attained due to inefficiencies of
current probe design strategies.
Results: We present a novel three-step approach for the design of high-throughput microarray
assays for HLA typing. This approach first selects sequences containing the SNPs present in all
alleles of the locus of interest and next calculates the number of base changes necessary to convert
a candidate probe sequences to the closest subsequence within the set of sequences that are likely
to be present in the sample including the remainder of the human genome in order to identify those
candidate probes which are "ultraspecific" for the allele of interest. Due to the high specificity of
these sequences, it is possible that preliminary steps such as PCR amplification are no longer
necessary. Lastly, the minimum number of these ultraspecific probes is selected such that the
highest resolution typing can be achieved for the minimal cost of production. As an example, an
array was designed and in silico results were obtained for typing of the HLA-B locus.
Conclusion: The assay presented here provides a higher resolution than has previously been
developed and includes more alleles than previously considered. Based upon the in silico and
preliminary experimental results, we believe that the proposed approach can be readily applied to
any highly polymorphic gene system.
Background
The HLA (human leukocyte antigen) system, the group of
genes in the human MHC (major histocompatibility com-
plex) located on chromosome VI, encodes the cell-surface
antigen-presenting proteins. HLA antigens are the major
determinants used by the body's immune system for rec-
ognition and differentiation of self from non-self (for-
eign) substances. This system consists of numerous SNPs
(single nucleotide polymorphisms) encoding more than
2,000 known alleles [1]. The allelic composition in the
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HLA loci, or the HLA type, varies significantly within the
population. Research has identified a direct correlation
between an individual's HLA type and his susceptibility to
disease including Hodgkin's lymphoma [2], preeclampsia
[3], diabetes [4], and Alzheimer's [5]. An individual's
response to viral infection or drug treatment is also
affected by their HLA type, e.g. variability in the course of
human immunodeficiency virus type 1 (HIV-1) infection
was shown to be partially the result of particular polymor-
phism in the HLA regions [6]. Furthermore, a single allele-
level mismatch between a transplant donor and acceptor
can dramatically reduce the survival rate of the recipient.
The HLA types of the donors and acceptors have a signifi-
cant effect on the occurrences of graft-versus-host disease
(GVHD), engraftment failure, and graft-versus-leukemia
effect [7,8].
Several different techniques have been explored for HLA
typing. Historically, serological analysis of allele-specific
sera was used to identify the structural differences on the
surface of the HLA molecules due to the nucleotide
present at the site of the polymorphism. This method,
however, is limited by the availability of allele-specific
sera and by its inability to discriminate between allelic
subtypes within each serologic family [9]. An alternative
means of typing is sequencing of the polymorphisms
within the HLA loci [10,11]. For HLA class II genes, many
of the polymorphisms are contained within exon 2 thus
necessitating sequencing of only a few hundred bases. In
contrast, the polymorphisms of class I genes require sev-
eral exons to be sequenced which in turn introduces an
increase in cost as well as the probability of sequencing
errors. Furthermore, sequencing-based typing also suffers
from inherent issues in resolving some sequencing mis-
calls. Despite this, sequencing has a substantially higher
resolution than is possible with serological methods.
Numerous nucleic acid-based approaches have also been
used for genotyping the HLA loci. One such approach,
PCR-SSP (Polymerase Chain Reaction – Sequence Specific
Primers), employs specific primers targeting a particular
polymorphism such that the presence of the polymor-
phism results in amplification of the product [12].
Because the number of primers required depends upon
the number of polymorphisms in the particular locus of
interest, a large number of PCR reactions are typically
needed to complete the HLA typing. PCR-SSOP (Sequence
Specific Oligonucleotide Probes), another nucleic acid-
based method, relies on PCR amplification of the locus of
interest followed by probing with oligonucleotides
designed to recognize specific SNPs [13]. The PCR step is
essential for boosting the signal intensity and signal to
noise ratio. Direct hybridization between SSOP and
genomic DNA resulted in low signal intensity and the low
signal to noise ratio, which may make the results difficult
to interpret [14]. The resolution of both PCR-SSP and
PCR-SSOP typing is low to medium as SNPs that are
shared by several subtypes of the alleles often result in
ambiguities. Because a simple PCR-SSP or PCR-SSOP
hybridization might not result in the assignment of the
HLA type, nucleic acid-based assays using the microarray
technology have been tested for HLA typing within the
past few years [15-21]. Microarrays are ideally suited for
the high-throughput requirements by offering the conven-
ience of miniaturization and the ability to perform thou-
sands of hybridizations in a single experiment. This highly
parallel nature of the microarrays and their unique format
makes them ideally suited for field use as well. Microar-
ray-based typing methods thus far discussed in the litera-
ture have thus far been able to identify only 6% to 33% of
the allelic variations in the loci of interest.
Herein, a novel three-step approach for the development
of high-throughput microarray assays for HLA typing is
presented. First, candidate probe sequences (n-mers: sub-
sequences of length n) are selected which contain the
known SNPs present in the allelic sequences of the locus
(or loci) of interest. Next, each candidate probes sequence
is compared to the collection of sequences which are
likely to be present in the sample (the "synthetic back-
ground"), including the remainder of the human genome
and human-associated microbial genomic sequences. The
distance, or the number of base changes that are necessary
for a candidate probe sequence to be "converted" to the
nearest sequence present in the synthetic background, is
calculated for each probe. The candidate probes which are
significantly distant from the background are less likely to
misprime with, for instance, human genomic DNA. Such
candidate probes are "ultraspecific" for identification of
the allele even when foreign genomic material is present.
It is possible that use of such ultraspecific probe sequences
may eliminate the need of PCR amplification of the HLA
region. Lastly, the smallest set of ultraspecific probes is
selected such that the highest resolution typing can be
achieved with a minimal cost in producing the assay. As
an example, the proposed approach was applied to the
most polymorphic region of the HLA system, the HLA-B
locus.
Results
The proposed method comprises of three steps.
1. Selection of candidate probes: Select all short subse-
quences (n-mers) of length 16 to 22 nucleotides (16  n 
22) containing each SNP in the allelic sequences produc-
ing the set of all candidate probes.
2. Identification of ultraspecific probes: Exclude from con-
sideration all candidate probe sequences which are
present in or can be converted to a subsequence in theBMC Genomics 2009, 10:85 http://www.biomedcentral.com/1471-2164/10/85
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synthetic background given any combination of two or
more base change as such sequences are likely to have a
high probability of mispairing with non-target DNA
present in the sample. The results of this most computa-
tionally intensive step is the set of ultraspecific candidate
probes or those sequences which are "distant" from the
background collection.
3. Selection of optimal set of ultraspecific probes: Deter-
mine the set of ultraspecific probe sequences which
requires the minimum number of members such that
each known allele is expected to hybridize with a specific
subset of probes.
For each of the 889 alleles within the HLA-B locus, the set
of all 16- through 22-mer sequences were identified as
candidate probe sequences. Thus, multiple n-mers con-
taining the same SNP for the same allele were identified in
which both the location of the SNP within the n-mer and
the length of the n-mer vary. To utilize these probes as
markers of the HLA-B specific polymorphisms, each of the
candidate probes were compared to the background col-
lection – the remainder of the human genome which
includes the other highly similar HLA loci (e.g. HLA-A has
89% sequence similarity and HLA-C has 93% sequence
similarity with HLA-B) and known polymorphisms out-
side of the HLA-B region. With regards to the ability to
detect the set of alleles, all of the alleles contain 16-
through 22-mers that are at least 1 change away. Table 1
lists the percentage of the alleles which can be detected by
probes of a particular size and distance from the back-
ground; a complete listing of the number of candidate
probes for each of the individual 889 alleles and distance
values can be found in Additional File 1. To reduce the
likelihood that probes would hybridize to non-target
sequence by tolerating single base mispairing(s), we stip-
ulate that ultraspecific n-mers must be 2 or more changes
away from the background.
While these ultraspecific probe sequences, when incorpo-
rated in a microarray assay, are expected to be able to
detect all of the 889 alleles considered, it is not guaranteed
that a single assay could distinguish between different
alleles. Thus, the set of ultraspecific probe sequences was
analyzed using a greedy algorithm (see Methods) in order
to generate the minimum set of ultraspecific probes
required such that all of the alleles can be detected with
the highest typing resolution possible. Based upon the
results of our computations, a probe set including 115
ultraspecific probes was identified. Ultraspecific probes
included in the set were selected based upon their ability
to both detect the 889 alleles as well as their ability to pro-
vide resolution for distinguishing between alleles. Each
allele is expected to hybridize with between two to 19 dif-
ferent probes in this set. While all ultraspecific probes are
able to distinguish one to many different targets, not all
members of the set provide the ability to indentify a par-
ticular allele (distinguishability). This set will produce dis-
tinctive hybridization patterns for 634 out of the 889
alleles such that 72.33% of the alleles can not only be
detected but also definitively typed; the remaining 255
alleles, while detectable by this probe set, will not hybrid-
ize to any unique or unique combination of ultraspecific
probe sequences.
As shown in Figure 1, the first five probes selected in the
set are able to detect alleles but do not provide any distinc-
tion between the alleles detected; with the inclusion of the
sixth probe, however, it is now possible to distinguish
between the expected hybridization patterns of the
B_1303 and B_560502 alleles from all other alleles con-
sidered. While the complete set of 115 ultraspecific probes
can recognize 634 alleles, 40 of these ultraspecific probes
are actually able to individually distinguish between 509
alleles (57.26%). Additional File 2 lists each of the
ultraspecific probe sequences included in the set. The per-
centage of the 634 distinguishable alleles each of these
probes is expected to hybridize with is shown in Figure 2.
As is shown in this figure, nearly half (49.57%) of the
probes included in the set are only expected to hybridize
with a single allele thus generating a unique hybridization
pattern such that the particular allele can be uniquely
identified from all of the other alleles considered.
Table 1: Percentage of the 889 alleles that have at least one probe sequence for the lengths calculated for each of the distances from 
the background collection sequences.
Candidate Probe Length
Distance 16 17 18 19 20 21 22
1 100% 100% 100% 100% 100% 100% 100%
2 56.36% 99.55% 99.89% 100% 100% 100% 100%
3 0% 0% 0.11% 53.66% 93.36% 97.30% 99.89%
4+ 0% 0% 0% 0% 0% 7.87% 13.61%BMC Genomics 2009, 10:85 http://www.biomedcentral.com/1471-2164/10/85
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In silico assays for the 115 ultraspecific probe set and each
of the alleles were conducted. As one would expect, it is
the groups of highly similar alleles that the ultraspecific
probe set is unable to distinguish between. In order to vis-
ualize the degree of similarity between the alleles based
upon their expected hybridization patterns, we calculated
the distance (D) between any two patterns as:
where n1 and n2 are the numbers of probes present in each
of alleles being compared and n12 is number of probes
present in both alleles simultaneously. By computing the
distances between each pair of 889 patterns (the distance
matrix) with PHYLIP's neighbor program [22], we were
able to group alleles using the publicly available NJPlot
software package [23] based on the distances between pat-
terns observed on the microarray. The tree was generated
for the set of alleles which cannot be individually typed.
Figure 3 illustrates a subtree in this tree; the NEWICK file
for the complete tree can be found in Additional File 3.
Discussion and conclusion
The microarray of 115 probes represents what many
researchers can produce in-house at low cost. While una-
ble to uniquely identify every allele, the probe set pre-
sented here provides a higher resolution than has
previously been developed and includes more alleles than
previously considered. For the 255 alleles which cannot
be distinguished, the nucleotide(s) present at the poly-
morphic positions defining the allele are included in can-
didate probe sequences that did not meet the
ultraspecificity criteria. Incorporating probe sequences
expected to hybridize within these polymorphic sites have
a greater likelihood of interacting with regions outside of
the HLA-B exons. As our goal here is to develop an assay
such that amplification of the HLA loci exon prior to
assaying is not necessary, such nonspecific probe
sequences are excluded from the set. In the event that the
assay generates a hybridization pattern common amongst
several known alleles, further high resolution typing may
be required. Furthermore, this assay lends itself towards
exploratory typing. In the event that a novel hybridization
pattern is observed, subsequent sequencing can be per-
formed to determine the sequence of the new allele; when
a known allele is encountered, however, the cost of this
additional sequencing can be avoided. Based upon the
results of in silico experiments as well as preliminary exper-
imental results (Hogan et al., unpublished results), we
believe that the proposed approach can be readily applied
to the entire HLA system as well as other highly polymor-
phic gene systems. We are in the process of developing an
"HLA-chip" to enable population-scale HLA typing in a
portable, field-ready environment.
Methods
Sequence data
The catalogued set of resequenced alleles for class I HLA-
B was retrieved from the IMGT/HLA Sequence Database
(release 2.17 04/2007) [1]. The IMGT/HLA database pro-
vides multiple alignment for the allelic sequences with
allele B*070201 as a reference. The aligned sequences are
in a format such that the SNPs are clearly marked indicat-
ing the differences between the alleles. As specified by the
IMGT database, this release contains 889 alleles within
the HLA-B locus.
Sequences containing these SNPs from the allele exons
were screened against the synthetic background of the set
of genomic sequences likely to appear in the sample. This
synthetic background includes the human genome (Build
36.1) with the exception of the HLA-B locus. The synthetic
background was created by referencing the annotation
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Allele groupings based on the similarity of the observed hybridization patterns for the microarray of 115 ultraspecific probes Figure 3
Allele groupings based on the similarity of the observed hybridization patterns for the microarray of 115 
ultraspecific probes.
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(GenBank summary file) of the human genome build and
removing the HLA-B locus' nucleotide sequence from the
complete sequence of chromosome 6 ftp://
ftp.ncbi.nih.gov/genomes/H_sapiens/ARCHIVE/
BUILD.36.1/Assembled_chromosomes/. For simplicity,
all  n-mers containing unknown/unidentified characters
were excluded from the calculations. The original and
complementary strands were considered for both the
HLA-B locus and the synthetic background collection.
Candidate probe selection
All of the 16- through 22-mer sequences containing the
SNPs present in each of the 889 allele sequences were
identified. Based upon the results of calculations per-
formed for the complete human genomic sequence for n
<18, it was discovered that only when n  16 that the
human genome does not include a sequence within two
changes of any selected n-mer [24]. Thus, candidate probe
sequences less than 16 nucleotides long were not calcu-
lated as they would be removed from further considera-
tion in the next step. Because the resolution of HLA typing
using ultraspecific sequences longer than 22 did not pro-
vide any better resolution of typing (data not shown),
computations for n greater than 22 are excluded from the
results presented here.
Identification of ultraspecific candidate probes
Using specialized algorithms and data structures [24], we
rigorously computed what sequences are present in both
the sequence of interest and present in the background as
well as the number of base changes necessary to "convert"
every n-mer contained within the sequence of interest to
any n-mer present in the background collection. If any
one combination is present in the background, for
instance given two base changes, the n-mer is said to be
two changes away from the nearest background sequence
or "two away". By calculating the number of changes away
each of the candidate probe sequences identified in the
first step is from the background, it is possible to identify
those candidate probes which are sufficiently "distant"
from the background and thus have a reduced probability
of hybridizing with non-target genomic material present
in the sample.
Probe set selection
To serotype HLA alleles, an assay must be able to not only
detect the presence of the allele but also reliably distin-
guish between allelic variations. The issue of detection
necessitates one to identify the set of ultraspecific candi-
date probes which are expected to hybridize with the par-
ticular allele. The ability to distinguish between alleles can
be rather straightforward if each allele contains at least
one candidate probe which is only expected to hybridize
with that particular allele. Due to the high sequence simi-
larity between the HLA-B alleles, however, the vast major-
ity of the 889 alleles do not contain a unique candidate
probe. The microarray platform provides an alternative
means for approaching this challenge – rather than type a
particular allele by a single unique probe, an allele can be
identified by a unique set of probes such that an allele can
be distinguished from another allele by its pattern of
hybridization. A naïve solution is to incorporate all of the
ultraspecific candidate probes. Due to the fact that the cost
of microarray assays is directly proportionate to the
number of probes included, it is ideal to design the assay
with the minimal number of probes necessary in order to
minimize cost and increase the ease in analyzing the assay
results.
The problem of identifying the minimum number of
probes to detect and distinguish a set of targets is an
instance of the classical set cover problem, a well studied
computational problem which is known to be NP Com-
plete. Several algorithms have been designed to approxi-
mate the minimum probe set [24-29]. Herein we have
developed another approach which has been integrated
into our suite of algorithms and data structures. Our
approach uses a greedy search strategy which is fast but
does not guarantee to find the smallest probe set to detect
and distinguish among all alleles. For each of the candi-
date probes, we calculate explicitly which targets the
probe covers (is expected to hybridize with). We then
cycle through a process of assessing the best candidate
probe in terms of both the number of targets it will cover
and its ability to improve the resolution in which individ-
ual targets can be identified. This selection process
chooses probes that provide both coverage and distin-
guishability. In the event that the set of candidate probes
remaining can provide only improved coverage or distin-
guishability, the probe set is assessed to see if the mini-
mum coverage (number of times each target allele is
expected to hybridize) specified by the user is met in
which case candidate probes providing improved distin-
guishability are selected.
Once a probe is selected, it is included within the probe
set and all targets that are covered by this probe and are
distinguishable from all other targets are removed from
consideration when assessing a future candidate probe's
coverage of targets. Likewise, one can stipulate that each
target is expected to hybridize with at least x different
probes, in order to improve the reliability of the assay,
such that when a probe is selected only targets meeting
this threshold are removed from further consideration.
This process of probe assessment and selection is repeated
until either (a) all of the targets are expected to be detected
by the probe set and distinguishable from either other
based upon the subset of probes expected to hybridize
with the individual target or (b) there are no more probes
which can improve the detection and distinguishability ofBMC Genomics 2009, 10:85 http://www.biomedcentral.com/1471-2164/10/85
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the set of targets. This approach was implemented a set of
C++ data structures and efficient algorithms to select fea-
sible sets among a large set of probes in a matter of sec-
onds to minutes.
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